TET2 and angioimmunoblastic T-cell lymphoma: Similar to other lymphomas, mutations of genes that regulate the epigenome are frequent in PTCL, and loss of function mutations in the TET2 gene is likely to be a founder mutation in angioimmunoblastic lymphoma (AITL).